CURR CANCER DRUG TAR 润色咨询

CURRENT CANCER DRUG TARGETS

出版年份:2001 年文章数:1180 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:1.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

投稿信息

投稿信息
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
1.2 %
年文章数
1180
期刊官网
点击查看 (点击次数:9170)
点击查看 (点击次数:2015次)
作者需知
点击查看 (点击次数:616次)
期刊简介
稿件收录要求

Published by Bentham Science Publishers. ISSN: 1568-0096.

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.

Current Cancer Drug Targets publishes original research articles, letters, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.

As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.